Abstract
Publication details
- DOI
- 10.4103/ojo.ojo_226_23
- Journal
- Oman Journal of Ophthalmology, 16(3), 397-398
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Al-Kalbani, K., & Ganesh, A. (2023). Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query. Oman Journal of Ophthalmology, 16(3), 397-398. https://doi.org/10.4103/ojo.ojo_226_23
MLA 9
Al-Kalbani, Khulood, and Anuradha Ganesh. "Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query." Oman Journal of Ophthalmology, vol. 16, no. 3, 2023, pp. 397-398. https://doi.org/10.4103/ojo.ojo_226_23.
Chicago (author–date)
Al-Kalbani, Khulood, and Anuradha Ganesh. 2023. "Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query." Oman Journal of Ophthalmology 16 (3): 397-398. https://doi.org/10.4103/ojo.ojo_226_23.
Harvard
Al-Kalbani, K. and Ganesh, A. (2023) 'Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query', Oman Journal of Ophthalmology, 16(3), pp. 397-398. doi:10.4103/ojo.ojo_226_23.
Vancouver
Al-Kalbani K, Ganesh A. Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query. Oman Journal of Ophthalmology. 2023;16(3):397-398. doi:10.4103/ojo.ojo_226_23
IEEE
K. Al-Kalbani, and A. Ganesh, "Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query," Oman Journal of Ophthalmology, vol. 16, no. 3, pp. 397-398, 2023, doi: 10.4103/ojo.ojo_226_23.